Corvus Pharmaceuticals (CRVS) Price to Book Value: 4.069

Corvus Pharmaceuticals, Inc. (CRVS)

10.90 -0.03 (-0.27%) USD | NASDAQ | Oct 02, 16:00

10.91 +0.01 (+0.09%) After-Hours: 20:00

Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2016. Start Trial.

Date	Value
October 02, 2026	4.069
October 01, 2026	4.080
September 30, 2026	4.301
September 29, 2026	4.390
September 28, 2026	4.431
September 25, 2026	4.338
September 24, 2026	4.405
September 23, 2026	4.682
September 22, 2026	5.018
September 21, 2026	4.637
September 18, 2026	4.689
September 17, 2026	4.685
September 16, 2026	4.566
September 15, 2026	4.835
September 14, 2026	4.894
September 11, 2026	4.820
September 10, 2026	4.831
September 09, 2026	4.976
September 08, 2026	5.200
September 04, 2026	5.372
September 03, 2026	5.469
September 02, 2026	5.301
September 01, 2026	5.327
August 31, 2026	5.242
August 28, 2026	5.286

Date	Value
August 27, 2026	5.495
August 26, 2026	5.499
August 25, 2026	5.436
August 24, 2026	5.260
August 21, 2026	5.398
August 20, 2026	5.350
August 19, 2026	5.749
August 18, 2026	5.536
August 17, 2026	5.566
August 14, 2026	5.559
August 13, 2026	5.652
August 12, 2026	5.619
August 11, 2026	5.499
August 10, 2026	5.130
August 07, 2026	5.197
August 06, 2026	5.174
August 05, 2026	5.200
August 04, 2026	5.197
August 03, 2026	4.991
July 31, 2026	4.950
July 30, 2026	4.924
July 29, 2026	4.868
July 28, 2026	4.969
July 27, 2026	4.823
July 24, 2026	4.879

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks